MD SB693 | 2017 | Regular Session
Status
Sponsorship: Slight Partisan Bill (Republican 7-4)
Status: Introduced on February 3 2017 - 25% progression, died in committee
Action: 2017-03-01 - Hearing 3/01 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 3 2017 - 25% progression, died in committee
Action: 2017-03-01 - Hearing 3/01 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring the Secretary of Health and Mental Hygiene to establish specified guidelines for the co-prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized to prescribe monitored prescription drugs; requiring the guidelines to address the co-prescribing of opioid overdose reversal drugs for specified patients; etc.
Title
Co-Prescribing Naloxone Saves Lives Act of 2017
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-03-01 | Senate | Hearing 3/01 at 1:00 p.m. |
| 2017-02-03 | Senate | First Reading Finance |
Subjects
Controlled Dangerous Substances
Drugs
Emergencies
Health
Health and Mental Hygiene, Department of
Health Occupations
Licenses
Patients
Pharmacists and Pharmacies
Public Health
Substance Abuse
Drugs
Emergencies
Health
Health and Mental Hygiene, Department of
Health Occupations
Licenses
Patients
Pharmacists and Pharmacies
Public Health
Substance Abuse
